

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.04469306 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.77922199 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.74522344 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63291231 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.63291231 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.31333196 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.31333196 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.89112300 |
| 9 | drug metabolic process (GO:0017144) | 6.72661354 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.38972779 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.23005318 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.23005318 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.23005318 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.09539025 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.03883539 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.86677692 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.80160034 |
| 18 | oxidative demethylation (GO:0070989) | 5.72449698 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.63332423 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.59568078 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.59529536 |
| 22 | phenylpropanoid metabolic process (GO:0009698) | 5.56627622 |
| 23 | ethanol metabolic process (GO:0006067) | 5.45924935 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.43354376 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.40167671 |
| 26 | cysteine metabolic process (GO:0006534) | 5.39789259 |
| 27 | protein carboxylation (GO:0018214) | 5.38074887 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38074887 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.37977463 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.37946690 |
| 31 | * urea cycle (GO:0000050) | 5.35878437 |
| 32 | * urea metabolic process (GO:0019627) | 5.35878437 |
| 33 | hormone catabolic process (GO:0042447) | 5.21371811 |
| 34 | bile acid metabolic process (GO:0008206) | 5.16844279 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.15812216 |
| 36 | alkaloid metabolic process (GO:0009820) | 5.13200988 |
| 37 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.08098561 |
| 38 | regulation of complement activation (GO:0030449) | 5.03066619 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 5.01867249 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91814594 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.90892589 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.89951893 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.89636124 |
| 44 | * nitrogen cycle metabolic process (GO:0071941) | 4.88560794 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.87567861 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.83320221 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.80271319 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.80271319 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.80271319 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.66438437 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.66438437 |
| 52 | lysine catabolic process (GO:0006554) | 4.64275097 |
| 53 | lysine metabolic process (GO:0006553) | 4.64275097 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.63705290 |
| 55 | * alpha-amino acid catabolic process (GO:1901606) | 4.62485724 |
| 56 | phospholipid efflux (GO:0033700) | 4.61577791 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.60242968 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.60242968 |
| 59 | negative regulation of hemostasis (GO:1900047) | 4.54691389 |
| 60 | negative regulation of blood coagulation (GO:0030195) | 4.54691389 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.50580714 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.50091142 |
| 63 | glycine metabolic process (GO:0006544) | 4.48904108 |
| 64 | regulation of plasminogen activation (GO:0010755) | 4.47847972 |
| 65 | flavonoid metabolic process (GO:0009812) | 4.42278450 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.42017143 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 4.41136070 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.39750065 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.39119783 |
| 70 | cellular glucuronidation (GO:0052695) | 4.37412134 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.32706006 |
| 72 | amine catabolic process (GO:0009310) | 4.32706006 |
| 73 | cholesterol efflux (GO:0033344) | 4.27362712 |
| 74 | glutamate metabolic process (GO:0006536) | 4.26308709 |
| 75 | * cellular amino acid catabolic process (GO:0009063) | 4.26164535 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.22954758 |
| 77 | ethanol oxidation (GO:0006069) | 4.16518739 |
| 78 | negative regulation of coagulation (GO:0050819) | 4.15327021 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.14531648 |
| 80 | heme transport (GO:0015886) | 4.11063777 |
| 81 | negative regulation of wound healing (GO:0061045) | 4.07798811 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 4.07456227 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 4.07212629 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07109404 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 4.05735591 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05529642 |
| 87 | aldehyde catabolic process (GO:0046185) | 4.04387308 |
| 88 | fibrinolysis (GO:0042730) | 3.99474232 |
| 89 | drug catabolic process (GO:0042737) | 3.96219849 |
| 90 | ketone body metabolic process (GO:1902224) | 3.89664537 |
| 91 | uronic acid metabolic process (GO:0006063) | 3.88093397 |
| 92 | glucuronate metabolic process (GO:0019585) | 3.88093397 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87050503 |
| 94 | regulation of bile acid biosynthetic process (GO:0070857) | 3.86570955 |
| 95 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.86504985 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.83082399 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82521208 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82521208 |
| 99 | S-adenosylmethionine metabolic process (GO:0046500) | 3.80531517 |
| 100 | drug transmembrane transport (GO:0006855) | 3.80314256 |
| 101 | cofactor catabolic process (GO:0051187) | 3.79873787 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.79810032 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.79624795 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.79096337 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.78243182 |
| 106 | acute-phase response (GO:0006953) | 3.76770314 |
| 107 | complement activation (GO:0006956) | 3.76479498 |
| 108 | cytolysis (GO:0019835) | 3.75455651 |
| 109 | protein activation cascade (GO:0072376) | 3.74405897 |
| 110 | xenobiotic metabolic process (GO:0006805) | 3.74144050 |
| 111 | * carboxylic acid catabolic process (GO:0046395) | 3.73661447 |
| 112 | * organic acid catabolic process (GO:0016054) | 3.73661447 |
| 113 | sterol homeostasis (GO:0055092) | 3.73375256 |
| 114 | negative regulation of lipase activity (GO:0060192) | 3.72653691 |
| 115 | short-chain fatty acid metabolic process (GO:0046459) | 3.70774495 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 3.70220883 |
| 117 | primary alcohol catabolic process (GO:0034310) | 3.67248547 |
| 118 | regulation of humoral immune response (GO:0002920) | 3.67028169 |
| 119 | angiotensin maturation (GO:0002003) | 3.66136631 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.65661229 |
| 121 | intestinal cholesterol absorption (GO:0030299) | 3.64631092 |
| 122 | intestinal absorption (GO:0050892) | 3.64568550 |
| 123 | daunorubicin metabolic process (GO:0044597) | 3.64467894 |
| 124 | polyketide metabolic process (GO:0030638) | 3.64467894 |
| 125 | doxorubicin metabolic process (GO:0044598) | 3.64467894 |
| 126 | protein-lipid complex assembly (GO:0065005) | 3.63879974 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 3.63403605 |
| 128 | fructose metabolic process (GO:0006000) | 3.61107190 |
| 129 | * arginine metabolic process (GO:0006525) | 3.61020130 |
| 130 | steroid catabolic process (GO:0006706) | 3.58798147 |
| 131 | positive regulation of blood coagulation (GO:0030194) | 3.58729429 |
| 132 | positive regulation of hemostasis (GO:1900048) | 3.58729429 |
| 133 | NAD biosynthetic process (GO:0009435) | 3.58022864 |
| 134 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55101442 |
| 135 | drug transport (GO:0015893) | 3.54337275 |
| 136 | NADH metabolic process (GO:0006734) | 3.52737845 |
| 137 | negative regulation of protein activation cascade (GO:2000258) | 3.47222227 |
| 138 | lipoprotein metabolic process (GO:0042157) | 3.40258017 |
| 139 | positive regulation of coagulation (GO:0050820) | 3.34044157 |
| 140 | lipoprotein transport (GO:0042953) | 3.31944118 |
| 141 | primary alcohol metabolic process (GO:0034308) | 3.30563665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39747770 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22184381 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.13689331 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52210492 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.26765026 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12487607 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78024338 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05570255 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.00909004 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08530078 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06567080 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9841931 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93458521 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64760751 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61229348 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60297902 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49948405 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43672767 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42012538 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39795513 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21170794 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20415019 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20021580 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19041672 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15767774 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03872718 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03824908 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03515176 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00671444 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00267621 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98232643 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97639809 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95733975 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95383063 |
| 35 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.91485969 |
| 36 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87902227 |
| 37 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87307725 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86261512 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84431446 |
| 40 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83394449 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83211380 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83038514 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80509704 |
| 44 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80454250 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80161764 |
| 46 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.78649148 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.78393434 |
| 48 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.78052071 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77996484 |
| 50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75644041 |
| 51 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74571012 |
| 52 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74283353 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71643246 |
| 54 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71506333 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.70986210 |
| 56 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70511318 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70273816 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70102655 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69219622 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68276089 |
| 61 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.68145728 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68062474 |
| 63 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.67214821 |
| 64 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66811477 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66367015 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66019883 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 0.65878558 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.65685120 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65283156 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65283156 |
| 71 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.64588338 |
| 72 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63767275 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63123000 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.62949879 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62847935 |
| 76 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.62506145 |
| 77 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61774852 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61001010 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.60631003 |
| 80 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.60559408 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60340097 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.59314705 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.58454810 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58038087 |
| 85 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.57753236 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.57737880 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.56981580 |
| 88 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.56794143 |
| 89 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.56418249 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56414911 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.56267134 |
| 92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55241584 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54749902 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54457891 |
| 95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54425733 |
| 96 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.53876055 |
| 97 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53816009 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52262593 |
| 99 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52262032 |
| 100 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51953490 |
| 101 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51882178 |
| 102 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50317779 |
| 103 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50211840 |
| 104 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49896028 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49757835 |
| 106 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.48514170 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47588273 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46739780 |
| 109 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45396244 |
| 110 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44587464 |
| 111 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43892860 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43401714 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43230995 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43063858 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43016743 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42231931 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41997589 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41686425 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41300248 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40553654 |
| 121 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39929439 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38810416 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38800030 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38563688 |
| 125 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38410877 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38217513 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37977193 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36593073 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36300537 |
| 130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36183334 |
| 131 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35775563 |
| 132 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35058708 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34942164 |
| 134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.34672892 |
| 135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34368209 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33743180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.54229682 |
| 2 | * MP0005360_urolithiasis | 7.04671110 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.68953867 |
| 4 | MP0005365_abnormal_bile_salt | 6.35667225 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.25154569 |
| 6 | MP0003252_abnormal_bile_duct | 4.07731942 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.70745094 |
| 8 | MP0009840_abnormal_foam_cell | 3.35270318 |
| 9 | * MP0003806_abnormal_nucleotide_metabolis | 3.31494675 |
| 10 | MP0005083_abnormal_biliary_tract | 3.13305740 |
| 11 | MP0003195_calcinosis | 2.86179612 |
| 12 | MP0005332_abnormal_amino_acid | 2.83923733 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.76006114 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.29758367 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.21860586 |
| 16 | MP0000609_abnormal_liver_physiology | 2.21731229 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.15271622 |
| 18 | MP0003868_abnormal_feces_composition | 2.00959256 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.00896699 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.88317059 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.66253536 |
| 22 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.53555775 |
| 23 | * MP0001764_abnormal_homeostasis | 1.49927494 |
| 24 | MP0005451_abnormal_body_composition | 1.45735831 |
| 25 | MP0003011_delayed_dark_adaptation | 1.42538835 |
| 26 | MP0003186_abnormal_redox_activity | 1.31037732 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.26918413 |
| 28 | * MP0009643_abnormal_urine_homeostasis | 1.22213515 |
| 29 | * MP0000598_abnormal_liver_morphology | 1.17882696 |
| 30 | MP0005647_abnormal_sex_gland | 1.16682612 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.15460014 |
| 32 | MP0000604_amyloidosis | 1.08272132 |
| 33 | MP0009764_decreased_sensitivity_to | 1.07527432 |
| 34 | MP0002254_reproductive_system_inflammat | 1.05985872 |
| 35 | * MP0009763_increased_sensitivity_to | 0.99624346 |
| 36 | MP0004147_increased_porphyrin_level | 0.99562323 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.96882739 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.94575625 |
| 39 | MP0010155_abnormal_intestine_physiology | 0.93588106 |
| 40 | MP0005408_hypopigmentation | 0.91529356 |
| 41 | MP0008469_abnormal_protein_level | 0.91139453 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.89767821 |
| 43 | MP0003879_abnormal_hair_cell | 0.87986406 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.83074357 |
| 45 | MP0009765_abnormal_xenobiotic_induced | 0.81006222 |
| 46 | MP0002876_abnormal_thyroid_physiology | 0.80093577 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.79930414 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 0.77289435 |
| 49 | * MP0005376_homeostasis/metabolism_phenot | 0.76451891 |
| 50 | MP0005670_abnormal_white_adipose | 0.76407678 |
| 51 | MP0002971_abnormal_brown_adipose | 0.72301169 |
| 52 | * MP0006036_abnormal_mitochondrial_physio | 0.72201568 |
| 53 | MP0005334_abnormal_fat_pad | 0.70914274 |
| 54 | MP0004130_abnormal_muscle_cell | 0.69627471 |
| 55 | MP0005266_abnormal_metabolism | 0.68340805 |
| 56 | MP0009053_abnormal_anal_canal | 0.68176016 |
| 57 | * MP0009697_abnormal_copulation | 0.67593361 |
| 58 | MP0003690_abnormal_glial_cell | 0.67524013 |
| 59 | MP0001661_extended_life_span | 0.66998431 |
| 60 | MP0000639_abnormal_adrenal_gland | 0.62034063 |
| 61 | MP0003329_amyloid_beta_deposits | 0.61818502 |
| 62 | MP0009785_altered_susceptibility_to | 0.60867406 |
| 63 | MP0001756_abnormal_urination | 0.59498742 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.59286505 |
| 65 | MP0005448_abnormal_energy_balance | 0.58969865 |
| 66 | MP0005187_abnormal_penis_morphology | 0.58270774 |
| 67 | MP0005409_darkened_coat_color | 0.57884746 |
| 68 | * MP0005535_abnormal_body_temperature | 0.57671081 |
| 69 | MP0002822_catalepsy | 0.55729242 |
| 70 | MP0005058_abnormal_lysosome_morphology | 0.54266949 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.52267631 |
| 72 | MP0009379_abnormal_foot_pigmentation | 0.51247921 |
| 73 | MP0003718_maternal_effect | 0.50683204 |
| 74 | MP0002928_abnormal_bile_duct | 0.49561536 |
| 75 | MP0005395_other_phenotype | 0.49081088 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.47278114 |
| 77 | MP0008873_increased_physiological_sensi | 0.46289799 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.46041854 |
| 79 | MP0008874_decreased_physiological_sensi | 0.45769396 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.45449748 |
| 81 | MP0001915_intracranial_hemorrhage | 0.44101880 |
| 82 | MP0003724_increased_susceptibility_to | 0.42802372 |
| 83 | MP0003953_abnormal_hormone_level | 0.42723596 |
| 84 | MP0008872_abnormal_physiological_respon | 0.42222483 |
| 85 | MP0005166_decreased_susceptibility_to | 0.41842044 |
| 86 | MP0004381_abnormal_hair_follicle | 0.41639882 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.41489976 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.41387812 |
| 89 | MP0002249_abnormal_larynx_morphology | 0.41210569 |
| 90 | MP0003075_altered_response_to | 0.40866237 |
| 91 | MP0003436_decreased_susceptibility_to | 0.40761224 |
| 92 | MP0001663_abnormal_digestive_system | 0.40341764 |
| 93 | MP0001664_abnormal_digestion | 0.39477743 |
| 94 | MP0005023_abnormal_wound_healing | 0.38335696 |
| 95 | MP0000538_abnormal_urinary_bladder | 0.38174941 |
| 96 | MP0009672_abnormal_birth_weight | 0.38043351 |
| 97 | MP0000579_abnormal_nail_morphology | 0.37795714 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.36361933 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.36350469 |
| 100 | MP0002796_impaired_skin_barrier | 0.36024858 |
| 101 | MP0004043_abnormal_pH_regulation | 0.35686467 |
| 102 | MP0003866_abnormal_defecation | 0.35140337 |
| 103 | MP0000477_abnormal_intestine_morphology | 0.34927622 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.34215334 |
| 105 | MP0009115_abnormal_fat_cell | 0.33792509 |
| 106 | MP0005164_abnormal_response_to | 0.33729119 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.32966536 |
| 108 | MP0006082_CNS_inflammation | 0.32569041 |
| 109 | MP0000249_abnormal_blood_vessel | 0.32257319 |
| 110 | MP0001243_abnormal_dermal_layer | 0.32116701 |
| 111 | MP0004883_abnormal_blood_vessel | 0.31457211 |
| 112 | MP0002132_abnormal_respiratory_system | 0.30983226 |
| 113 | MP0002970_abnormal_white_adipose | 0.29930727 |
| 114 | MP0001853_heart_inflammation | 0.29821568 |
| 115 | MP0001881_abnormal_mammary_gland | 0.29441703 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.29264930 |
| 117 | MP0002168_other_aberrant_phenotype | 0.29104223 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.27559843 |
| 119 | * MP0001845_abnormal_inflammatory_respons | 0.26814361 |
| 120 | MP0005025_abnormal_response_to | 0.25936523 |
| 121 | MP0002060_abnormal_skin_morphology | 0.25863938 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.25452093 |
| 123 | MP0002090_abnormal_vision | 0.24737793 |
| 124 | MP0000566_synostosis | 0.24020771 |
| 125 | MP0001986_abnormal_taste_sensitivity | 0.23100580 |
| 126 | MP0000467_abnormal_esophagus_morphology | 0.23039367 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.22749027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.47844015 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46609816 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.46295415 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.73531785 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.63878781 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.59847973 |
| 7 | Xanthomatosis (HP:0000991) | 6.29965591 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.52599860 |
| 9 | Complement deficiency (HP:0004431) | 5.45348790 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.86288867 |
| 11 | Joint hemorrhage (HP:0005261) | 4.81167529 |
| 12 | Epidermoid cyst (HP:0200040) | 4.57070226 |
| 13 | Hyperglycinemia (HP:0002154) | 4.50016943 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.46248591 |
| 15 | * Hyperammonemia (HP:0001987) | 4.44265155 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.44225096 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.27558310 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26439786 |
| 19 | Fat malabsorption (HP:0002630) | 4.25676139 |
| 20 | Ketosis (HP:0001946) | 4.25387927 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15193644 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.14627513 |
| 23 | Hyperglycinuria (HP:0003108) | 3.99264298 |
| 24 | Abnormality of complement system (HP:0005339) | 3.97540908 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.97506357 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.97506357 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.89953609 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.88239411 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.87114872 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80226113 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.65492445 |
| 32 | * Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.63241542 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.39555539 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38821735 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33863299 |
| 36 | Steatorrhea (HP:0002570) | 3.17839087 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.13641742 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07078806 |
| 39 | Ketoacidosis (HP:0001993) | 3.04086142 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 2.99130735 |
| 41 | Glycosuria (HP:0003076) | 2.99130735 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.98480156 |
| 43 | Spontaneous abortion (HP:0005268) | 2.97541215 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.97335811 |
| 45 | Osteomalacia (HP:0002749) | 2.94172909 |
| 46 | Myocardial infarction (HP:0001658) | 2.92391310 |
| 47 | Skin nodule (HP:0200036) | 2.80915221 |
| 48 | Metabolic acidosis (HP:0001942) | 2.79125875 |
| 49 | * Abnormality of serum amino acid levels (HP:0003112) | 2.77052608 |
| 50 | Hyperphosphaturia (HP:0003109) | 2.73697319 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.72660424 |
| 52 | Acanthocytosis (HP:0001927) | 2.71269729 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.66498503 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.60237295 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60237295 |
| 56 | Vascular calcification (HP:0004934) | 2.56308559 |
| 57 | * Lethargy (HP:0001254) | 2.53303233 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.50856991 |
| 59 | Spastic diplegia (HP:0001264) | 2.48052425 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.47028653 |
| 61 | Glomerulonephritis (HP:0000099) | 2.45208412 |
| 62 | Abnormal urine phosphate concentration (HP:0012599) | 2.41283971 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40827818 |
| 64 | Cholelithiasis (HP:0001081) | 2.40061488 |
| 65 | Mitral stenosis (HP:0001718) | 2.37423958 |
| 66 | Gout (HP:0001997) | 2.35272562 |
| 67 | Neonatal onset (HP:0003623) | 2.35207129 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.34034816 |
| 69 | Cholecystitis (HP:0001082) | 2.34034816 |
| 70 | Reduced antithrombin III activity (HP:0001976) | 2.32303534 |
| 71 | Malnutrition (HP:0004395) | 2.32299650 |
| 72 | Proximal tubulopathy (HP:0000114) | 2.28160559 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.26895239 |
| 74 | Pulmonary embolism (HP:0002204) | 2.24847119 |
| 75 | Elevated alkaline phosphatase (HP:0003155) | 2.22810305 |
| 76 | Amyloidosis (HP:0011034) | 2.22511950 |
| 77 | Purpura (HP:0000979) | 2.21015993 |
| 78 | Esophageal varix (HP:0002040) | 2.19552970 |
| 79 | Widely patent fontanelles and sutures (HP:0004492) | 2.19220670 |
| 80 | Hypophosphatemia (HP:0002148) | 2.19191241 |
| 81 | Gingival bleeding (HP:0000225) | 2.18928993 |
| 82 | * Irritability (HP:0000737) | 2.16085430 |
| 83 | Pancreatitis (HP:0001733) | 2.15528490 |
| 84 | Menorrhagia (HP:0000132) | 2.15345285 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.14244601 |
| 86 | * Cerebral edema (HP:0002181) | 2.13664244 |
| 87 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.13156360 |
| 88 | Late onset (HP:0003584) | 2.10698373 |
| 89 | Brushfield spots (HP:0001088) | 2.10522267 |
| 90 | Neonatal hypoglycemia (HP:0001998) | 2.09894636 |
| 91 | Fair hair (HP:0002286) | 2.09063501 |
| 92 | Enlarged kidneys (HP:0000105) | 2.08444782 |
| 93 | Poikilocytosis (HP:0004447) | 2.07600001 |
| 94 | Nephrolithiasis (HP:0000787) | 2.07584425 |
| 95 | Generalized aminoaciduria (HP:0002909) | 2.04558820 |
| 96 | Thrombophlebitis (HP:0004418) | 2.04382882 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02865598 |
| 98 | Opisthotonus (HP:0002179) | 2.02330885 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 2.00933376 |
| 100 | * Vomiting (HP:0002013) | 1.98638845 |
| 101 | Nausea (HP:0002018) | 1.97046951 |
| 102 | Hemorrhage of the eye (HP:0011885) | 1.96565545 |
| 103 | Rickets (HP:0002748) | 1.94638384 |
| 104 | Cerebral palsy (HP:0100021) | 1.92537676 |
| 105 | Renal cortical cysts (HP:0000803) | 1.90745491 |
| 106 | Abnormality of the Achilles tendon (HP:0005109) | 1.89807713 |
| 107 | Facial shape deformation (HP:0011334) | 1.89639878 |
| 108 | Potter facies (HP:0002009) | 1.89639878 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 1.89484173 |
| 110 | Hydroxyprolinuria (HP:0003080) | 1.88750470 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 1.88750470 |
| 112 | Pigmentary retinal degeneration (HP:0001146) | 1.88268374 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 1.88126291 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86567892 |
| 115 | Ileus (HP:0002595) | 1.84541174 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84446113 |
| 117 | Hypophosphatemic rickets (HP:0004912) | 1.83386801 |
| 118 | Elevated hepatic transaminases (HP:0002910) | 1.82360767 |
| 119 | Confusion (HP:0001289) | 1.82120750 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.81275723 |
| 121 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.81195889 |
| 122 | Status epilepticus (HP:0002133) | 1.78195235 |
| 123 | Hyperglycemia (HP:0003074) | 1.74326546 |
| 124 | Nephritis (HP:0000123) | 1.73899754 |
| 125 | Hyperuricemia (HP:0002149) | 1.73062035 |
| 126 | Increased purine levels (HP:0004368) | 1.73062035 |
| 127 | Abnormality of vitamin B metabolism (HP:0004340) | 1.72040246 |
| 128 | Acute hepatic failure (HP:0006554) | 1.71213607 |
| 129 | Abdominal distention (HP:0003270) | 1.68158806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.17744320 |
| 2 | ACVR1B | 6.15439069 |
| 3 | SIK1 | 4.54422218 |
| 4 | FGFR4 | 4.54326291 |
| 5 | ERN1 | 4.20049997 |
| 6 | TAOK3 | 3.24327912 |
| 7 | INSRR | 3.00892436 |
| 8 | ERBB4 | 2.94139780 |
| 9 | MST1R | 2.33391119 |
| 10 | MAP2K4 | 2.30456073 |
| 11 | PRKG2 | 2.29662859 |
| 12 | PKN2 | 2.25775015 |
| 13 | PRPF4B | 1.97436507 |
| 14 | FLT3 | 1.93790168 |
| 15 | MAPK11 | 1.92964700 |
| 16 | PIK3CG | 1.90027093 |
| 17 | MAP3K12 | 1.79858389 |
| 18 | FRK | 1.76070798 |
| 19 | LATS1 | 1.71995656 |
| 20 | PDK2 | 1.68598284 |
| 21 | TYK2 | 1.67911100 |
| 22 | TRIB3 | 1.58012839 |
| 23 | MAP3K2 | 1.56952440 |
| 24 | DAPK2 | 1.55124985 |
| 25 | PTK6 | 1.48627508 |
| 26 | ABL2 | 1.48291676 |
| 27 | MYLK | 1.46142219 |
| 28 | NEK9 | 1.41525210 |
| 29 | FGFR2 | 1.41149484 |
| 30 | KDR | 1.24759310 |
| 31 | EPHA2 | 1.22218945 |
| 32 | JAK2 | 1.22002830 |
| 33 | STK39 | 1.21636931 |
| 34 | TESK2 | 1.21287163 |
| 35 | MAP3K7 | 1.19986168 |
| 36 | PRKAA2 | 1.14492017 |
| 37 | GRK6 | 1.13301267 |
| 38 | PINK1 | 1.09484114 |
| 39 | ERBB2 | 1.09014431 |
| 40 | TBK1 | 1.05129658 |
| 41 | MAP3K10 | 1.04864403 |
| 42 | OXSR1 | 1.03641234 |
| 43 | MAP2K3 | 0.99282152 |
| 44 | NLK | 0.99263531 |
| 45 | JAK1 | 0.98908931 |
| 46 | MAPK4 | 0.98852621 |
| 47 | MAP3K14 | 0.98136935 |
| 48 | STK38L | 0.96730813 |
| 49 | PRKCZ | 0.93819940 |
| 50 | MET | 0.90459450 |
| 51 | MAP3K11 | 0.86031122 |
| 52 | EPHB2 | 0.85786693 |
| 53 | MAPK15 | 0.84952230 |
| 54 | MAP2K6 | 0.83863443 |
| 55 | MAP3K3 | 0.83529658 |
| 56 | CDK6 | 0.83148906 |
| 57 | PRKACG | 0.77362565 |
| 58 | FER | 0.76873021 |
| 59 | CAMK2G | 0.75318670 |
| 60 | MAPK12 | 0.72892843 |
| 61 | EPHB1 | 0.72676197 |
| 62 | TIE1 | 0.72596819 |
| 63 | EPHA3 | 0.69915991 |
| 64 | IRAK3 | 0.69683025 |
| 65 | LMTK2 | 0.69070443 |
| 66 | PRKACA | 0.68943591 |
| 67 | CSK | 0.68507382 |
| 68 | PRKG1 | 0.67440546 |
| 69 | PRKAA1 | 0.66942990 |
| 70 | MAP4K1 | 0.66799326 |
| 71 | CAMK1D | 0.66793308 |
| 72 | DYRK1B | 0.66787335 |
| 73 | GSK3A | 0.65968647 |
| 74 | RIPK1 | 0.64458584 |
| 75 | SGK3 | 0.59387267 |
| 76 | PBK | 0.59356292 |
| 77 | SRC | 0.57941776 |
| 78 | IKBKE | 0.54980109 |
| 79 | PTK2 | 0.54818106 |
| 80 | FGFR3 | 0.54811388 |
| 81 | MAPK7 | 0.53769477 |
| 82 | TGFBR2 | 0.52629397 |
| 83 | GRK1 | 0.52329869 |
| 84 | PRKCQ | 0.52292363 |
| 85 | CSF1R | 0.51988919 |
| 86 | ZAP70 | 0.51301203 |
| 87 | CSNK1G1 | 0.50168671 |
| 88 | TAOK2 | 0.50102870 |
| 89 | PRKCB | 0.49984317 |
| 90 | CASK | 0.49969439 |
| 91 | MATK | 0.49744499 |
| 92 | PDPK1 | 0.48638570 |
| 93 | EPHA4 | 0.48268407 |
| 94 | PIM1 | 0.45451709 |
| 95 | KSR2 | 0.45128410 |
| 96 | IGF1R | 0.43771479 |
| 97 | NTRK3 | 0.43480814 |
| 98 | MAP2K1 | 0.43239263 |
| 99 | MAP3K5 | 0.42448502 |
| 100 | CDK4 | 0.42387406 |
| 101 | SGK2 | 0.42288007 |
| 102 | BMPR2 | 0.41128466 |
| 103 | DDR2 | 0.40376226 |
| 104 | RET | 0.39275922 |
| 105 | SGK1 | 0.39138254 |
| 106 | CDC42BPA | 0.39095807 |
| 107 | MAP3K13 | 0.38895512 |
| 108 | PRKCG | 0.38508853 |
| 109 | JAK3 | 0.37585308 |
| 110 | PKN1 | 0.36035507 |
| 111 | ICK | 0.34933464 |
| 112 | TNIK | 0.34028961 |
| 113 | PRKCD | 0.33768603 |
| 114 | CAMK4 | 0.33378653 |
| 115 | EGFR | 0.31793621 |
| 116 | YES1 | 0.30593398 |
| 117 | FYN | 0.30488174 |
| 118 | MTOR | 0.30317811 |
| 119 | MAP3K6 | 0.30077242 |
| 120 | MAP2K2 | 0.29786393 |
| 121 | PDK1 | 0.29722438 |
| 122 | PDGFRA | 0.29350057 |
| 123 | CSNK1G2 | 0.29236983 |
| 124 | CAMKK2 | 0.28867930 |
| 125 | CAMK2D | 0.28770478 |
| 126 | PIK3CA | 0.28263971 |
| 127 | CSNK1A1 | 0.28207994 |
| 128 | SGK494 | 0.28118994 |
| 129 | SGK223 | 0.28118994 |
| 130 | RPS6KA3 | 0.27965666 |
| 131 | PRKCA | 0.27771226 |
| 132 | IRAK2 | 0.25583413 |
| 133 | CSNK1G3 | 0.25171070 |
| 134 | NUAK1 | 0.24031137 |
| 135 | MAP3K1 | 0.23324588 |
| 136 | PAK3 | 0.22322430 |
| 137 | PDK3 | 0.22065332 |
| 138 | PDK4 | 0.22065332 |
| 139 | IRAK1 | 0.21507940 |
| 140 | AKT3 | 0.20938151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54627380 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68008041 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40686826 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35985389 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 2.86268688 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75044861 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70795427 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65786476 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63695819 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53169266 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49204031 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39258203 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28151998 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15989004 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14535949 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06872286 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95704676 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94330767 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94261349 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93611999 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93211509 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84223038 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79129132 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78763770 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76038217 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74250102 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73268974 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72425364 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71726821 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66516731 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60137605 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58160443 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55447146 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.49973960 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49727562 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49672601 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43902125 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38811292 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36473491 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32696193 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31088325 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30419654 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23767394 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21979927 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20718761 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.20010599 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13356610 |
| 48 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11237524 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04248306 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03203231 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99722661 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98388888 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98274401 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96316782 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94227035 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89003682 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87272366 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83753701 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81745801 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77060092 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70322537 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67648582 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67149246 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58011447 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.53703667 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53373670 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48336082 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46229821 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45901185 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37696415 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.36479627 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28446479 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25643299 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25070826 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22690633 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.21215077 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20243771 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19320045 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15042852 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07912043 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04966998 |
| 82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03698818 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.02774599 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00410483 |
| 85 | Pertussis_Homo sapiens_hsa05133 | -0.2563049 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2518695 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2427904 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | -0.2412262 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2185325 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.2110782 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2015248 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1981541 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1859219 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1805789 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1772585 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1629760 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1525598 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1516330 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1464613 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1446514 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1398777 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1311484 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1145933 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1123326 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1116089 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0792628 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0498681 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0201657 |

